Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.
作者信息
Cockle Julia V, Picton Susan V, Melcher Alan
机构信息
Leeds Institute of Cancer Studies & Pathology, St James's Hospital, Leeds University, LS9 7TF, UK.
出版信息
CNS Oncol. 2013 Jul;2(4):307-10. doi: 10.2217/cns.13.25.
Abstract
摘要
相似文献
1
Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.
CNS Oncol. 2013 Jul;2(4):307-10. doi: 10.2217/cns.13.25.
2
[Oncolytic viruses for therapy of malignant glioma].
Biomed Khim. 2016 May;62(4):376-90. doi: 10.18097/PBMC20166204376.
3
The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies.
Viruses. 2021 Jun 17;13(6):1158. doi: 10.3390/v13061158.
4
Oncolytic Virotherapy by HSV.
Adv Exp Med Biol. 2018;1045:63-84. doi: 10.1007/978-981-10-7230-7_4.
5
Oncolytic Virotherapy in Glioma Tumors.
Int J Mol Sci. 2020 Oct 14;21(20):7604. doi: 10.3390/ijms21207604.
6
Therapeutic potency of oncolytic virotherapy-induced cancer stem cells targeting in brain tumors, current status, and perspectives.
J Cell Biochem. 2019 Mar;120(3):2766-2773. doi: 10.1002/jcb.27661. Epub 2018 Oct 15.
7
Targeting pediatric cancer stem cells with oncolytic virotherapy.
Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15.
8
Translational research in oncolytic measles virotherapy: early discoveries and future steps.
Future Microbiol. 2011 Feb;6(2):125-8. doi: 10.2217/fmb.10.170.
9
Oncolytic adenoviruses for the treatment of brain tumors.
Curr Opin Mol Ther. 2010 Oct;12(5):530-7.
10
Viruses in the treatment of malignant glioma.
Expert Rev Neurother. 2007 Apr;7(4):321-4. doi: 10.1586/14737175.7.4.321.
引用本文的文献
1
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies.
Molecules. 2018 Oct 8;23(10):2565. doi: 10.3390/molecules23102565.
2
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.
Mol Ther Oncolytics. 2017 May 2;5:75-86. doi: 10.1016/j.omto.2017.04.002. eCollection 2017 Jun 16.
本文引用的文献
1
Brainstem glioma: a review.
Curr Neurol Neurosci Rep. 2013 May;13(5):346. doi: 10.1007/s11910-013-0346-3.
2
Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.
Front Oncol. 2013 Feb 28;3:28. doi: 10.3389/fonc.2013.00028. eCollection 2013.
3
Atypical teratoid rhabdoid tumor: current therapy and future directions.
Front Oncol. 2012 Sep 12;2:114. doi: 10.3389/fonc.2012.00114. eCollection 2012.
4
Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology.
Front Oncol. 2012 Aug 24;2:105. doi: 10.3389/fonc.2012.00105. eCollection 2012.
5
Pediatric neuro-oncology: current status and future directions.
Asia Pac J Clin Oncol. 2012 Sep;8(3):223-31. doi: 10.1111/j.1743-7563.2012.01558.x. Epub 2012 Jun 18.
6
Oncolytic virotherapy.
Nat Biotechnol. 2012 Jul 10;30(7):658-70. doi: 10.1038/nbt.2287.
7
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.
J Virol. 2012 May;86(9):5304-13. doi: 10.1128/JVI.06998-11. Epub 2012 Feb 29.
8
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma.
Neuro Oncol. 2012 Apr;14(4):459-70. doi: 10.1093/neuonc/nor231. Epub 2012 Feb 3.
9
A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.
Neuro Oncol. 2011 Jan;13(1):14-27. doi: 10.1093/neuonc/noq148. Epub 2010 Nov 12.
10
Oncolytic virotherapy reaches adolescence.
Pediatr Blood Cancer. 2010 Dec 15;55(7):1253-63. doi: 10.1002/pbc.22724. Epub 2010 Aug 23.
Zotero 插件